GLPG 1972

Drug Profile

GLPG 1972

Alternative Names: GLPG1972

Latest Information Update: 10 Mar 2017

Price : $50

At a glance

  • Originator Galapagos NV; Servier
  • Class Antirheumatics; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Osteoarthritis

Most Recent Events

  • 23 Feb 2017 Galapagos plans a phase Ib study with GLPG 1972 in Osteoarthritis in the US
  • 01 Aug 2016 Galapagos completes a phase-I clinical trial in Osteoarthritis (In volunteers) in Netherlands (PO) (NCT02851485)
  • 01 Jul 2016 Phase-I clinical trials in Osteoarthritis (In volunteers) in Netherlands (PO) (NCT02851485)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top